±èÈ¿Á¤

  • Áø·á°ú

    ¼ÒÈ­±â³»°ú

  • Àü¹®Áø·áºÐ¾ß

    ´ã¼®Áõ, ´ã³¶Áúȯ, ´ã³¶, ´ãµµ¾Ï, ÃéÀåÁúȯ

  • ´ã´çŬ¸®´Ð

  • °ü·Ã¼¾ÅÍ

    ¼ÒÈ­±â³»½Ã°æ¼¾ÅÍ , ÃéÀå¾Ï ¼¾ÅÍ , ´ãµµ¡¤´ã°ü¾Ï ¼¾ÅÍ

±èÈ¿Á¤

±èÈ¿Á¤ ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
¼ÒÈ­±â³»°ú -
¿ÀÈÄ
-
¿ÀÈÄ
- - ´ã¼®Áõ, ´ã³¶Áúȯ, ´ã³¶, ´ãµµ¾Ï, ÃéÀåÁúȯ

±èÈ¿Á¤ ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  • 1990 .03  ~  1996 .02  :  °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¹¾÷,Çлç
  • 1999 .03  ~  2001 .03  :  °í·Á´ëÇб³ ÀÇÇдëÇпø ³»°úÇÐ, ¼®»ç
  • 2001 .03  ~  2003 .08  :  °í·Á´ëÇб³ ÀÇÇдëÇпø ³»°úÇÐ, ¹Ú»ç

°æ·Â

more
  • 2001 .03  ~  2003 .02  :  °í·Á´ëÇб³ ÀÇ·á¿ø ¼ÒÈ­±â³»°ú ÀüÀÓÀÇ
  • 2003 .03  ~  2007 .02  :  °­¿ø´ëÇб³ ÀÇ°ú´ëÇÐ ¼ÒÈ­±â³»°ú Á¶±³¼ö
  • 2007 .03  ~  2011 .02  :  ÇѸ²´ëÇб³ °­³²¼º½Éº´¿ø ¼ÒÈ­±â³»°ú Á¶±³¼ö

³í¹®

more
  • [±¹³»³í¹®] °£³» ´ã°ü¾Ï¿¡¼­ 17¹ø ¿°»öüÀÇ ÀÌÇüÁ¢ÇÕ¼Ò½Ç ¹ß»ý ºóµµ
  • [±¹³»³í¹®] °£³»´ã¼®Áõ ¹× °£³»´ã°ü¾Ï¿¡¼­ Epidermal Growth Factor Receptor, ErbB2, Matrix Metalloproteinase-9 ¹ßÇö
  • [±¹³»³í¹®] ´ã¼® ¼ººÐ¿¡ µû¸¥ ´ã³¶Á¡¸·ÀÇ MUC3, MUC5AC, MUC6 ¹× Epidermal Growth Factor Receptor ¹ßÇö
  • [±¹³»³í¹®] ´Ü¼ø °£³¶Á¾°ú °£³»´ã°ü ³¶¼ºÁ¾¾çÀÇ Ç÷û ¹× ¸é¿ªÁ¶Á÷È­Çп°»ö¿¡¼­ CA19-9 ÀÇÀÇ
  • [±¹¿Ü³í¹®] (Increased expression of mucin 5AC mRNA and decreased expression of epidermal growth-factor receptor mRNA in gallstone patients)

ÃÖÁ¾¼öÁ¤ÀÏ : 2023.05.08